Sunwin Stevia International Begins Production of Enzyme Treated Stevia Extract and Receives First Purchase Order for 3,500 Kilograms

QUFU, China, May 7, 2014

Enzyme treated stevia is one of the most advanced types of steviosides produced in the world for use in the food and beverage industries. While stevia has been growing in popularity in recent years as an all natural sweetener, its applications have been limited in part because it often exhibits a bitter, licorice-like aftertaste. Enzyme treated stevia is produced by the addition of glucose to stevia extracts using a-glucosyltransferase. This new method can effectively decrease or even eliminate the bitter aftertaste of natural stevia.

"We are excited to add enzyme treated stevia to our commercial product offerings making Sunwin Stevia one of a select few suppliers capable of producing this extract on a large scale basis." commented Dongdong Lin, CEO of Sunwin Stevia. "We believe our technology is state of the art and enzyme treated stevia has the potential to vastly expand the market in the years to come.  We look forward to actively marketing our enzyme treated stevia in Europe and North America and expanding our sales in this important new product category."

About Sunwin Stevia International, Inc.

Sunwin Stevia International, Inc. (OTCQB: SUWN) engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts).  As an industry leader in agricultural processing, Sunwin Stevia has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin Stevia, please visit http://www.sunwininternational.com.

Safe Harbor Statement

Sunwin Stevia International, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our ability to return our revenues to historical levels, our dependence on continued market acceptance of our products, competition, our ability to control our raw material costs, risks associated with operating in China, and other risk factors impacting our company, some of which may be beyond our control.  We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2013.